Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pirbright supports global battle against COVID-19
More than 60 of Pirbright's diagnostic staff and scientists have volunteered to join the PHE COVID-19 testing effort.
Scientists utilising skills and equipment to support the testing effort

Researchers at The Pirbright Institute are utilising their unique facilities and expertise to help in the global battle against COVID-19.

Scientists are providing help in three key areas, allowing the UK to increase its capacity to test both NHS staff and patients and meet the Government’s pledge to deliver 100,000 COVID-19 diagnostic tests by the end of April.

Pirbright has supplied the UK's National Coronavirus Testing Centre in Milton Keynes with 13 of its high-throughput testing machines. Comprising seven nucleic acid extraction robots and six PCR machines, the equipment will be used to identify the presence of COVID-19 in samples taken from potentially infected people and/or healthcare workers.

Furthermore, more than 60 of Pirbright’s diagnostic staff and scientists have volunteered to join the testing effort at seven Public Health England testing sites across the nation. The volunteers have been working away from their families since 23 March and will be deployed on a rota basis for as long as is required.

Pirbright scientists with expertise in animal coronaviruses are also studying the virus (SARS-CoV-2) that causes COVID-19 to further understand its biology and how it infects cells. A vaccine trial is already underway, in which a potential vaccine is being tested on pigs.

“This work is a fantastic collaboration between world-leading medical and veterinary scientists in immunology, virology and molecular biology,” explained Dr Toby Tuthill, head of the virus programme at Pirbright.

“It will provide an evaluation of new SARS-CoV-2 vaccines in a relevant model and will also generate a panel of antibody-based tools which will help us understand virus structure and how it stimulates the immune response. These antibodies could also be developed as additional novel therapeutics to treat COVID-19”, he said.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.